Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Klabunde

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Chembiochem : a European Journal of Chemical Biology|October 4, 2002
Drug design strategies for targeting G-protein-coupled receptorsThomas Klabunde, Gerhard Hessler
Chembiochem : a European Journal of Chemical Biology|March 26, 2005
GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effectsThomas Klabunde, Andreas Evers
Journal of Medicinal Chemistry|February 18, 2005
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptorAndreas Evers, Thomas Klabunde
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
Understanding drugs and diseases by systems biology?Hans-Christoph Schneider, Thomas Klabunde
Journal of Chemical Information and Modeling|July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similaritiesThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screeningThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|August 19, 2005
Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocolsAndreas Evers, Gerhard Hessler, Hans Matter, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 7, 2016
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes SimulatorRoberto Visentin, Thomas Klabunde, Marshall Grant, et al.
Journal of Medicinal Chemistry|April 19, 2002
Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin IIStefanie Flohr, Michael Kurz, Evi Kostenis, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator<sup>.</sup>Roberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Chembiochem : a European Journal of Chemical Biology|October 4, 2002
Drug design strategies for targeting G-protein-coupled receptorsThomas Klabunde, Gerhard Hessler
Chembiochem : a European Journal of Chemical Biology|March 26, 2005
GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effectsThomas Klabunde, Andreas Evers
Journal of Medicinal Chemistry|February 18, 2005
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptorAndreas Evers, Thomas Klabunde
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
Understanding drugs and diseases by systems biology?Hans-Christoph Schneider, Thomas Klabunde
Journal of Chemical Information and Modeling|July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similaritiesThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screeningThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|August 19, 2005
Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocolsAndreas Evers, Gerhard Hessler, Hans Matter, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 7, 2016
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes SimulatorRoberto Visentin, Thomas Klabunde, Marshall Grant, et al.
Journal of Medicinal Chemistry|April 19, 2002
Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin IIStefanie Flohr, Michael Kurz, Evi Kostenis, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator<sup>.</sup>Roberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
Pageof 3